Rudolf Lucas
Oprichter bij APEPTICO Forschung & Entwicklung GmbH
Profiel
Rudolf Lucas is the founder of APEPTICO Forschung & Entwicklung GmbH, which was founded in 2008.
He held the title of Chief Scientific Officer at the company starting in 2010.
Dr. Lucas is currently working at Georgia Health Sciences University as a Professor since 2007.
In the past, he has worked at the University of Geneva, Weizmann Institute of Science, and Universität Konstanz, holding the title of Principal at each institution.
Actieve functies van Rudolf Lucas
| Bedrijven | Functie | Begin |
|---|---|---|
APEPTICO Forschung & Entwicklung GmbH
 APEPTICO Forschung & Entwicklung GmbH Miscellaneous Commercial ServicesCommercial Services APEPTICO Forschung & Entwicklung GmbH develops and commercializes peptide-based therapeutics. Its products targeting chronic and life-threatening diseases. The firms peptide molecules correspond to validated, pharmacodynamic active structures and domains of well-known proteins and biopharmaceuticals. The company was founded by Franz Knauseder, Bernhard Fischer, Rudolf Lucas and Hermann Mascher in 2008 and is headquartered in Vienna, Austria. | Oprichter | 20-01-2010 |
| Georgia Health Sciences University | Corporate Officer/Principal | 05-06-2009 |
Eerdere bekende functies van Rudolf Lucas
| Bedrijven | Functie | Einde |
|---|---|---|
| Weizmann Institute of Science | Corporate Officer/Principal | - |
| Universität Konstanz | Corporate Officer/Principal | - |
| University of Geneva | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
APEPTICO Forschung & Entwicklung GmbH
APEPTICO Forschung & Entwicklung GmbH Miscellaneous Commercial ServicesCommercial Services APEPTICO Forschung & Entwicklung GmbH develops and commercializes peptide-based therapeutics. Its products targeting chronic and life-threatening diseases. The firms peptide molecules correspond to validated, pharmacodynamic active structures and domains of well-known proteins and biopharmaceuticals. The company was founded by Franz Knauseder, Bernhard Fischer, Rudolf Lucas and Hermann Mascher in 2008 and is headquartered in Vienna, Austria. | Commercial Services |
